BIOLASE (NASDAQ:BIOL) Now Covered by StockNews.com

StockNews.com initiated coverage on shares of BIOLASE (NASDAQ:BIOL) in a research note released on Thursday. The firm issued a sell rating on the medical technology company’s stock.

A number of other analysts have also weighed in on the stock. Maxim Group lowered shares of BIOLASE from a strong-buy rating to a hold rating in a research report on Friday, May 24th. Benchmark reaffirmed a speculative buy rating and set a $0.40 price target on shares of BIOLASE in a research note on Tuesday, May 14th.

BIOLASE Stock Performance

NASDAQ BIOL opened at $0.14 on Thursday. The company has a current ratio of 1.17, a quick ratio of 0.64 and a debt-to-equity ratio of 34.06. The firm has a market capitalization of $4.80 million, a price-to-earnings ratio of -0.01 and a beta of 0.74. The firm’s 50 day simple moving average is $0.16 and its 200 day simple moving average is $0.47. BIOLASE has a 1 year low of $0.13 and a 1 year high of $10.31.

BIOLASE (NASDAQ:BIOL) last issued its earnings results on Monday, May 13th. The medical technology company reported ($0.36) earnings per share for the quarter. BIOLASE had a negative net margin of 43.56% and a negative return on equity of 1,782.73%. The company had revenue of $10.13 million during the quarter.

Hedge Funds Weigh In On BIOLASE

A hedge fund recently raised its stake in BIOLASE stock. Virtu Financial LLC increased its position in shares of BIOLASE, Inc. (NASDAQ:BIOL) by 1,068.0% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 143,537 shares of the medical technology company’s stock after buying an additional 131,248 shares during the period. Virtu Financial LLC owned 0.43% of BIOLASE worth $27,000 at the end of the most recent reporting period. Institutional investors own 8.79% of the company’s stock.

About BIOLASE

BIOLASE, Inc, together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications.